Genetic variation in IL28B is associated with chronic hepatitis C and treatment failure: a genome-wide association study A Rauch, Z Kutalik, P Descombes, T Cai, J Di Iulio, T Mueller, M Bochud, ... Gastroenterology 138 (4), 1338-1345. e7, 2010 | 1464 | 2010 |
Mapping the human genetic architecture of COVID-19 Writing group Writing group leaders Pathak Gita A. 6 Andrews Shea J. 7 Kanai ... Nature 600 (7889), 472-477, 2021 | 740 | 2021 |
Sex differences in nonalcoholic fatty liver disease: state of the art and identification of research gaps A Lonardo, F Nascimbeni, S Ballestri, DL Fairweather, S Win, TA Than, ... Hepatology 70 (4), 1457-1469, 2019 | 711 | 2019 |
Pathogenesis of chronic hepatitis C: immunological features of hepatic injury and viral persistence A Cerny, FV Chisari Hepatology 30 (3), 595-601, 1999 | 614 | 1999 |
Association of Hepatitis C Virus—Specific CD8+ T Cells with Viral Clearance in Acute Hepatitis C NH Grüner, TJ Gerlach, MC Jung, HM Diepolder, CA Schirren, ... The Journal of infectious diseases 181 (5), 1528-1536, 2000 | 533 | 2000 |
Randomized placebo-controlled trial of ursodeoxycholic acid with vitamin e in nonalcoholic steatohepatitis JF Dufour, CM Oneta, JJ Gonvers, F Bihl, A Cerny, JM Cereda, JF Zala, ... Clinical Gastroenterology and Hepatology 4 (12), 1537-1543, 2006 | 496 | 2006 |
HLA A2 restricted cytotoxic T lymphocyte responses to multiple hepatitis B surface antigen epitopes during hepatitis B virus infection. R Nayersina, P Fowler, S Guilhot, G Missale, A Cerny, HJ Schlicht, ... Journal of immunology (Baltimore, Md.: 1950) 150 (10), 4659-4671, 1993 | 452 | 1993 |
Naturally occurring dominant resistance mutations to hepatitis C virus protease and polymerase inhibitors in treatment‐naive patients T Kuntzen, J Timm, A Berical, N Lennon, AM Berlin, SK Young, B Lee, ... Hepatology 48 (6), 1769-1778, 2008 | 433 | 2008 |
Cytotoxic T lymphocyte response to hepatitis C virus-derived peptides containing the HLA A2. 1 binding motif. A Cerny, JG McHutchison, C Pasquinelli, ME Brown, MA Brothers, ... The Journal of clinical investigation 95 (2), 521-530, 1995 | 409 | 1995 |
CD8+ T lymphocyte responses are induced during acute hepatitis C virus infection but are not sustained F Lechner, NH Gruener, S Urbani, J Uggeri, T Santantonio, AR Kammer, ... European journal of immunology 30 (9), 2479-2487, 2000 | 399 | 2000 |
Genotype 3 is associated with accelerated fibrosis progression in chronic hepatitis C PY Bochud, T Cai, K Overbeck, M Bochud, JF Dufour, B Müllhaupt, ... Journal of hepatology 51 (4), 655-666, 2009 | 361 | 2009 |
Infective endocarditis: clinical spectrum, presentation and outcome. An analysis of 212 cases 1980–1995 ROM Netzer, E Zollinger, C Seiler, A Cerny Heart 84 (1), 25-30, 2000 | 273 | 2000 |
T cell-mediated hepatitis in mice infected with lymphocytic choriomeningitis virus. Liver cell destruction by H-2 class I-restricted virus-specific cytotoxic T cells as a … RM Zinkernagel, E Haenseler, T Leist, A Cerny, H Hengartner, A Althage The Journal of experimental medicine 164 (4), 1075-1092, 1986 | 252 | 1986 |
IL28B expression depends on a novel TT/-G polymorphism which improves HCV clearance prediction S Bibert, T Roger, T Calandra, M Bochud, A Cerny, N Semmo, FHT Duong, ... Journal of Experimental Medicine 210 (6), 1109-1116, 2013 | 244 | 2013 |
Insulin resistance is associated with liver fibrosis in non-diabetic chronic hepatitis C patients A Muzzi, G Leandro, L Rubbia-Brandt, R James, O Keiser, R Malinverni, ... Journal of hepatology 42 (1), 41-46, 2005 | 225 | 2005 |
Molecular mimicry of human cytochrome P450 by hepatitis C virus at the level of cytotoxic T cell recognition AR Kammer, SH van der Burg, B Grabscheid, IP Hunziker, ... The Journal of experimental medicine 190 (2), 169-176, 1999 | 224 | 1999 |
Genome-wide association study identifies variants associated with progression of liver fibrosis from HCV infection E Patin, Z Kutalik, J Guergnon, S Bibert, B Nalpas, E Jouanguy, ... Gastroenterology 143 (5), 1244-1252. e12, 2012 | 205 | 2012 |
Video-assisted thoracoscopic surgery for fibrinopurulent pleural empyema in 67 patients H Striffeler, M Gugger, MD Vinzenz Im Hof, A Cerny, M Furrer, HB Ris The Annals of thoracic surgery 65 (2), 319-323, 1998 | 200 | 1998 |
IL28B alleles associated with poor hepatitis C virus (HCV) clearance protect against inflammation and fibrosis in patients infected with non‐1 HCV genotypes PY Bochud, S Bibert, Z Kutalik, E Patin, J Guergnon, B Nalpas, ... Hepatology 55 (2), 384-394, 2012 | 198 | 2012 |
Comparative immunogenicity of a PreS/S hepatitis B vaccine in non-and low responders to conventional vaccine P Rendi-Wagner, D Shouval, B Genton, Y Lurie, H Rümke, G Boland, ... Vaccine 24 (15), 2781-2789, 2006 | 178 | 2006 |